Effect of Mother DHA Supplementation on Term Newborn.
NCT01947426 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2013-09-20
Summary
In the present study, we evaluate the effect of the mother suplementación with DHA during the gestation and lactation on diverse aspects of the development of newborn. The effect on the oxidative stress, inflammatory signaling, bone turnover and piscomotor and visual development was studied. Women will in the sixth month of pregnancy, consume a diet balanced during last 3 months of pregnancy and the whole lactation. In addition the women will divide in two groups: one will receive a supplement of docosahexaenoic acid (DHA) to evaluate the effects on the development of the newborn child; whereas another group will receive a placebo. Different samples of blood of the mother and of mother milk will be taken and we will correlating her lipidic profile with the brain development of the newborn child, evaluated by different tests.
Conditions
- Oxidative Stress
- Inflammation
- Infant Development
Interventions
- DIETARY_SUPPLEMENT
-
DHA Supplementation
mothers consuming 400 mg of DHA/day and their neonates
- DIETARY_SUPPLEMENT
-
Control (milk without DHA)
mothers consuming placebo product and their neonates
Sponsors & Collaborators
-
Puleva Biotech
collaborator INDUSTRY -
Universidad de Granada
lead OTHER
Principal Investigators
-
Julio J Ochoa · Universidad de Granada
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Max Age
- 40 Years
- Sex
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-04-30
- Primary Completion
- 2010-04-30
- Completion
- 2011-04-30
Countries
- Spain
Study Locations
More Related Trials
-
Effects of Prenatal DHA Supplements on Infant Development
NCT00646360 ·Status: COMPLETED ·Phase: NA
-
A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders
NCT02336243 ·Status: UNKNOWN ·Phase: PHASE3
-
Investigations on Improving Docosahexaenoic and Arachidonic Acid Content in Preterm Infant Formula
NCT01300130 ·Status: COMPLETED ·Phase: NA
-
A Randomized Clinical Trial on Supplementation of DHA and AA to Preterm Infants
NCT00226187 ·Status: COMPLETED ·Phase: NA
-
Observational Study of Infants Fed on DHA (Breast Source or Milk Formula Source ) and Its Effects on Covid-19 Infected Infants and Severity
NCT05071690 ·Status: UNKNOWN
-
Fish Oil and Folate Supplementation During Pregnancy
NCT01180933 ·Status: COMPLETED ·Phase: NA
-
N-3 Fatty Acid Requirements for Human Development
NCT00620672 ·Status: COMPLETED ·Phase: PHASE1
-
Fetal Programming of Immune Response and Body Fat by Maternal Obesity
NCT04249635 ·Status: COMPLETED
-
DHA Supplementation and Pregnancy Outcome
NCT02219399 ·Status: COMPLETED ·Phase: NA
-
Docosahexaenoic Acid (DHA) Supplementation in High Risk Pregnancies
NCT04069195 ·Status: UNKNOWN ·Phase: NA
-
Enteral Supplementation With Docosahexaenoic Acid and Arachidonic Acid (DHA-AA) in Preterm Infants
NCT06366893 ·Status: RECRUITING ·Phase: NA
-
Docosaexahenoic Acid and Gross Motor Milestones in Infants
NCT00610922 ·Status: COMPLETED ·Phase: NA
-
Maternal Omega-3 Supplementation to Reduce Bronchopulmonary Dysplasia
NCT02371460 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Effect of Omega-3 Supplementation During Pregnancy on Regulation of Stress
NCT01158976 ·Status: COMPLETED ·Phase: NA
-
Activity of Essential Fatty Acid Elongation/Desaturation Pathway During Early Life in Human Infants, In Vivo
NCT00342303 ·Status: COMPLETED
-
Early DHA Supplementation in Very Low Birth Weight Infants
NCT03192839 ·Status: COMPLETED ·Phase: NA
-
Improving Maternal and Child Health Through Prenatal Fatty Acid Supplementation
NCT02647723 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Diet and Physical Activity Counseling and n3-long Chain (PUFA) Supplementation in Obese Pregnant Women
NCT02574767 ·Status: COMPLETED ·Phase: NA
-
Bioavailability of Different Formulas Enriched With DHA Using Wet Mixing or Dry Blending Method
NCT04460287 ·Status: COMPLETED ·Phase: NA
-
Poly-unsaturated Fatty Acids and Developmental Dyslexia
NCT04287530 ·Status: RECRUITING ·Phase: NA
-
Omega-6/Omega-3 Ratio and Neural Development in Preterm Infants.
NCT02339727 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Docosahexaenoic Acid (DHA) on Fetal Cardiac Outcomes
NCT01007110 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Arachidonic Acid Supplementation in Infant Formula on the Immune Response of Infants
NCT02092857 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Long-Chain Polyunsaturated Fatty Acid Supplementation on Toddler Cognition
NCT00982462 ·Status: COMPLETED ·Phase: NA
-
Synergistic Activity of Human Milk Nutrients and Infant Cognition
NCT03838536 ·Status: RECRUITING ·Phase: NA